U of G Researchers Secure Federal Funding for Cancer and Chronic Pain Studies and More

Johnston Hall at U of G at dusk

 

From investigating the mechanisms of cancer cells and chronic pain to shaping new policies for microbiome health, nine University of Guelph researchers have received over $7.1 million in federal grants from the Canadian Institutes of Health Research (CIHR)

Insights from these projects could lead to new treatments for life-threatening diseases such as breast cancer, chronic kidney disease, leukemia, and more.  

College of Biological Science 

  • Dr. Nina Jones, MCB, has been granted $879,750 to study specialized kidney cells called podocytes, whose functions are disrupted during early kidney disease. 

  • Dr. Siavash Vahidi, MCB, has received $1,143,375 to investigate acute myeloid leukemia (AML) cells. 

College of Social and Applied Human Sciences 

Ontario Veterinary College 

  • Dr. Roger Moorehead, Department of Biomedical Sciences, has received $100,000 to study a protein shown to reduce the growth and spread of breast cancer cells to the lungs. 

  • Dr. Sarah Wootton, Department of Pathobiology, received $761,176 to enhance and expand her group’s patented alternative vaccine system, which has been shown to be effective against a range of infectious diseases, including Ebola and Pseudomonas aeruginosa

Read the full news release on the U of G News site: U of G Researchers Receive Federal Funding to Study Cancer, Chronic Pain and More